Reneo Pharmaceuticals, Inc.
Total Trades
7
Buys
4
Sells
2
Largest Trade
$1M+
Insiders
5
Institutional Funds
2
Inst. Value
$1M+
Activist Filings
14
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Leonard Braden Michael | 10% Owner | BUY | $100K–$500K | 98K | $1.47 | Sep 26, 2024 |
| Hall Ashley | Chief Development … | EXERCISE | $15K–$50K | 16K | $1.80 | Aug 29, 2023 |
| Hall Ashley | Chief Development … | SELL | $50K–$100K | 16K | $6.28 | Aug 29, 2023 |
| Novo Holdings A/S | 10% Owner | SELL | $500K+ | 100K | $7.10 | Jun 23, 2023 |
| O'Donnell Niall | Director | BUY | $1M+ | 125K | $8.00 | May 10, 2023 |
| Cruse Michael | COO | BUY | $15K–$50K | 8K | $3.39 | Sep 2, 2022 |
| Cruse Michael | COO | BUY | $15K–$50K | 7K | $3.20 | Aug 31, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2023 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 952K | $1M+ | SH |
| CITIGROUP INC | 526 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
RiverVest Venture Fund III, L.P.
SC 13D/A · Jan 21, 2025
0.2%
25K shares
Highbridge Capital Management, LLC
SC 13G · Nov 14, 2024
9.2%
3.1M shares
SC 13G · Sep 26, 2024
8.8%
2.9M shares
SC 13G/A · May 21, 2024
8.0%
2.7M shares
New Enterprise Associates 15, L.P.
SC 13D/A · May 8, 2024
14.3%
4.8M shares
SC 13G · Jan 16, 2024
4.1%
1.4M shares
SC 13D · Dec 26, 2023
10.0%
3.3M shares
SC 13D/A · Dec 15, 2023
0.0%
0 shares
I.R.S. IDENTIFICATION NO. RiverVest Venture Fund III, L.P.
SC 13D/A · May 30, 2023
1.0%
328K shares
SC 13D/A · May 15, 2023
10.2%
3.4M shares
SC 13D/A · May 9, 2023
8.2%
2.7M shares
SC 13D/A · Aug 11, 2022
8.5%
2.1M shares
SC 13D/A · Jan 27, 2022
14.0%
3.4M shares
Lundbeckfond Invest A/S (“Lundbeckfond”)
SC 13G · Jan 26, 2022
8.3%
2.0M shares